TabletsMRP Under Process
Official PMBI MRP is being updated for catalog code 2888.
Locate Jan Aushadhi KendraClinical Overview
Bepotastine Besilate (10mg) and Olopatadine (5mg) Tablets is an oral selective second-generation H1-receptor antagonist and mast cell stabilizer. It blocks peripheral H1 receptors and prevents mast cell degranulation, suppressing inflammatory cytokine (IL-5, leukotriene) release. Indicated for allergic rhinitis, pruritus, and chronic urticaria.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally twice daily (morning and evening) with water, with or without food. Swallow whole.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Drowsiness, dry mouth, nausea, headache, fatigue. Safe antiallergic profile.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
May cause mild drowsiness; caution while driving. Avoid concurrent alcohol.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, pulmonological diagnosis, or respiratory management recommendations. Inhalation therapies and allergy medications should be used strictly under the guidance of a qualified pulmonologist or registered medical practitioner.
Olopatadine Hydrochloride Ophthalmic Solution 0.1% w/v
Olopatadine Hydrochloride (0.1%, 0.2% w/v) is a dual-action mast cell stabilizer and selective histamine H1 receptor antagonist on the WHO Model List of Essential Medicines. It blocks H1 receptors on conjunctival nerves and vascular endothelium (providing rapid relief of itching within 30 minutes) and stabilizes mast cell membranes, inhibiting histamine, tryptase, and leukotriene degranulation. Indicated for the treatment of signs and symptoms of allergic conjunctivitis (seasonal and perennial).
Olopatadine Hydrochloride 0.4% w/v + Ketorolac 0.1 % w/v Ophthalmic Solution
Olopatadine Hydrochloride (0.1%, 0.2% w/v) is a dual-action mast cell stabilizer and selective histamine H1 receptor antagonist on the WHO Model List of Essential Medicines. It blocks H1 receptors on conjunctival nerves and vascular endothelium (providing rapid relief of itching within 30 minutes) and stabilizes mast cell membranes, inhibiting histamine, tryptase, and leukotriene degranulation. Indicated for the treatment of signs and symptoms of allergic conjunctivitis (seasonal and perennial).